Fuan Pharmaceutical Group Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fuan Pharmaceutical Group Co Ltd with three other
companies in this sector in CHINA :
Tianjin Tianyao Pharmaceutical, Ltd.
sales of 2.92 billion Chinese Renmimbi [US$408.64 million]
of which 51%
Shandong Jincheng Pharmaceutical Group Co Ltd
(2.79 billion Chinese Renmimbi [US$391.69 million]
of which 54%
was Intermediate), and
Hunan ER-KANG Pharmaceutical Co Ltd
(2.74 billion Chinese Renmimbi [US$384.62 million]
of which 94%
was pharmaceutic adjuvant;).
During the year ended December of 2019, sales at
Fuan Pharmaceutical Group Co Ltd were 2.78 billion Chinese Renmimbi (US$389.72 million).
increase of 4.2%
versus 2018, when the company's sales were 2.67 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Fuan Pharmaceutical Group Co Ltd
(and since 2014, sales have increased a total of 520%).
Sales of Preparation saw an increase
that was more than double the company's growth rate: sales were up
14.7% in 2019, from
1.55 billion Chinese Renmimbi to 1.78 billion Chinese Renmimbi.
Fuan Pharmaceutical Group Co Ltd also saw significant increases in sales in
Drug Distribution and Other (up 13.7% to 31.10 million Chinese Renmimbi)
Other (up 11.0% to 33.12 million Chinese Renmimbi)
Not all segments of Fuan Pharmaceutical Group Co Ltd experienced an increase in sales in 2019:
sales of Apis and Intermediates fell 11.6% to 936.74 million Chinese Renmimbi.